We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Treatment of symptomatic benign prostatic hyperplasia with beta-sitosterol: an 18-month follow-up.
- Authors
Berges, R R; Kassen, A; Senge, T
- Abstract
To determine the long-term effects of phytotherapy with beta-sitosterol (the trade name for beta-sitosterol used in this study is Harzol(R)) for symptomatic benign prostatic hyperplasia (BPH). Patient and methods At 18 months after enrolment in a 6-month multicentre double-blind placebo-controlled clinical trial with beta-sitosterol (reported previously), patients were re-evaluated using the modified Boyarsky score, the International Prostate Symptom Score and quality-of-life index, the maximum urinary flow rate (Qmax) and postvoid residual urine volume (PVR). In this open extension of the original trial (after 6 months of treatment or placebo), patients were free to chose their further treatment for BPH.
- Publication
BJU international, 2000, Vol 85, Issue 7, p842
- ISSN
1464-4096
- Publication type
Journal Article
- DOI
10.1046/j.1464-410x.2000.00672.x